Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 338,297 | 352,583 | 332,106 | 319,538 | 315,475 |
| Cost of Goods | 152,514 | 154,885 | 148,132 | 150,488 | 144,840 |
| Gross Profit | 185,783 | 197,698 | 183,974 | 169,050 | 170,635 |
| Operating Expenses | 120,812 | 119,820 | 122,918 | 106,111 | 108,563 |
| Operating Income | 65,485 | 78,763 | 61,188 | 63,427 | 62,912 |
| Interest Expense | 1,463 | 1,179 | 835 | 856 | 873 |
| Other Income | 456 | 444 | 444 | 513 | 473 |
| Pre-tax Income | 64,478 | 78,028 | 60,797 | 63,084 | 62,512 |
| Income Tax | 18,786 | 24,029 | 15,930 | 19,724 | 19,639 |
| Net Income Continuous | 45,692 | 53,999 | 44,867 | 43,360 | 42,873 |
| Minority Interests | 4 | 4 | 7 | 6 | 20 |
| Net Income | $45,688 | $53,995 | $44,860 | $43,354 | $42,853 |
| EPS Basic Total Ops | 0.44 | 0.51 | 0.41 | 0.40 | 0.39 |
| EPS Basic Continuous Ops | 0.44 | 0.50 | 0.41 | 0.40 | 0.39 |
| EPS Diluted Total Ops | 0.43 | 0.50 | 0.41 | 0.39 | 0.38 |
| EPS Diluted Continuous Ops | 0.43 | 0.50 | 0.40 | 0.39 | 0.38 |
| EBITDA(a) | $79,258 | $92,607 | $74,701 | $77,345 | $75,711 |